v3.26.1
SHAREHOLDERS’ EQUITY (DEFICIT) (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
SCHEDULE OF STOCK OPTION ACTIVITY

Stock option activity for the periods presented is as follows:

 

   Options  

Weighted

Average

Exercise Price

Per Share

  

Weighted

Average

Remaining

Contractual

Term (years)

 
Outstanding at December 31, 2024   18,614   $5.59    7.5 
Granted             
Cancelled   (911)   20.30      
Exercised             
Outstanding as of December 31, 2025   17,703   $4.94    6.5 
Exercisable as of December 31, 2025   16,200   $4.24      
SCHEDULE OF ALL STOCK OPTIONS OUTSTANDING

The following table summarizes the range of exercise price, weighted average remaining contractual life (“Life”) and weighted average exercise price (“Price”) for all stock options outstanding as of December 31, 2025:

 

   

Options

Outstanding

 
Exercise Price   Shares   Life (in years) 
$3.00    1,763    5.6 
$3.50    13,510    6.2 
$12.50    2,430    8.4 
      17,703    6.5 
SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS

The Black-Scholes option pricing model is used by the Company to determine the weighted-average fair value of share-based payments. The Company recognizes forfeitures as they occur. There were no stock options granted in the twelve months ended December 31, 2025.

 

  

For The Year Ending

December 31,

 
   2024 
Expected term   5.8 - 6.25 
Expected volatility   68%
Expected dividends   None 
Risk-free interest rate   3.8% - 4.5%
Forfeitures   None 
SCHEDULE OF RESTRICTED STOCK UNIT

Restricted stock unit activity for the period presented is as follows:

 

  

Restricted

Stock Units

  

Weighted Average

Grant Date

Fair Value

 
Outstanding at December 31, 2024   29,080   $18.75 
Granted   470,175    1.80 
Vested   (488,291)   2.50 
Forfeited        
Outstanding as of December 31, 2025   10,964   $6.64